IDBiologics is a human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Nashville
State: Tennessee
Zip:
Country: United States
IDBiologics was founded in 2017 to discover and develop human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases.Their innovative fully human monoclonal antibody platform enables rapid discovery and optimization of broad and potent therapeutic molecules.Using this proprietary platform, IDBiologics has accumulated unparalleled breadth in isolating antibodies for infectious diseases, with lead candidate molecules to diverse targets moving forward in development.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2022 | Seed Round | 1 | - |
Acequia Capital (AceCap) Acequia Capital (AceCap) |
5/2020 | Venture Round | 1 | $4.3M |
Flying Point Industries Flying Point Industries |
9/2021 | Grant | 1 | - |
Launch Tennessee Launch Tennessee |
9/2021 | Grant | 1 | - |
Launch Tennessee Launch Tennessee |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|